Cargando…
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
BACKGROUND: Communicating risk is difficult. Although different methods have been proposed – using numbers, words, pictures or combinations – none has been extensively tested. We used electronic and bibliographic searches to review evidence concerning risk perception and presentation. People tend to...
Autores principales: | Moore, R Andrew, Derry, Sheena, McQuay, Henry J, Paling, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374447/ https://www.ncbi.nlm.nih.gov/pubmed/18257914 http://dx.doi.org/10.1186/ar2373 |
Ejemplares similares
-
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006) -
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007) -
Topical NSAIDs for acute pain: a meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004) -
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004) -
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)